芪术温中汤治疗脾胃虚寒型慢性非萎缩性胃炎的临床观察

发布时间：2018-01-01 12:01

  本文关键词：芪术温中汤治疗脾胃虚寒型慢性非萎缩性胃炎的临床观察　出处：《黑龙江省中医药科学院》2016年硕士论文　论文类型：学位论文

  更多相关文章： 慢性非萎缩性胃炎 脾胃虚寒 芪术温中汤 临床观察

【摘要】：1.目的观察芪术温中汤治疗脾胃虚寒型慢性非萎缩性胃炎的临床疗效并对其进行客观评价,探讨芪术温中汤治疗脾胃虚寒型慢性非萎缩性胃炎的作用机制。2.方法选择符合脾胃虚寒型慢性非萎缩性胃炎患者60例纳入本研究。随机分为治疗组、对照组各30例,治疗组服用芪术温中汤,对照组服用附子理中丸,观察并对比治疗前后症状积分、证候疗效、胃镜结果及远期疗效。3.结果证候疗效:治疗组与对照组的症状积分均有改善,但治疗组优于对照组。治疗组证候疗效总有效率为96.7%,对照组为70.0%,总有效率治疗组高于对照组,且差异具有统计学意义(P0.05)。胃镜结果:治疗组胃镜改善总有效率为83.3%,对照组为53.3%,总有效率治疗组高于对照组,且差异具有统计学意义(P0.05)。H.pylori根除率:治疗组H.pylori阳性者21例,治疗后2例,总根除率为90.5%;对照组H.pylori阳性者19例,治疗后7例,总根除率为63.2%。H.pylori根除率治疗组高于对照组,且差异具有统计学意义(P0.05)。随访结果:随访第4周末,治疗组证候疗效总有效率为93.3%,对照组为56.7%,两组相比差异有统计学意义(P0.05)。疗程结束与随访第4周末的证候疗效进行组间对比,治疗组差异无统计学意义(P0.05);对照组差异有统计学意义(P0.05)。4.结论4.1芪术温中汤治疗脾胃虚寒型慢性非萎缩性胃炎临床疗效确切;4.2芪术温中汤在症状改善方面优于对照组;4.3芪术温中汤能改善胃镜下胃黏膜慢性炎症,疗效优于对照组;4.4芪术温中汤在根除H.pylori感染方面优于对照组;4.5芪术温中汤临床疗效稳定,远期疗效优于对照组。
[Abstract]:Objective To observe the clinical curative effect of 1. Qizhu Wenzhong Decoction in the treatment of spleen deficiency type chronic non atrophic gastritis and carries on the objective evaluation, to explore the mechanism of.2. method of Qizhu Wenzhong Decoction in the treatment of spleen deficiency type chronic non atrophic gastritis with spleen deficiency type of chronic non atrophic gastritis patients 60 cases were included in this study were divided. For the treatment group, the control group of 30 cases, the treatment group taking Qizhu Wenzhong decoction, the control group taking Fuzilizhong pill, observed and compared before and after treatment of symptoms, syndromes, endoscopy results and long-term efficacy results of.3. syndromes: symptom scores were the treatment group and the control group improved, but the treatment group better than the control group. The treatment group syndrome curative effect the total effective rate was 96.7%, the control group was 70%, the total effective rate of treatment group was higher than control group, and the difference was statistically significant (P0.05). The results of Gastroscope: the treatment group to improve the total efficiency of gastroscope 83.3%, the control group was 53.3%, the total efficiency of the treatment group than the control group, and the difference was statistically significant (P0.05) the eradication rate of.H.pylori: 21 patients in treatment group were H.pylori positive, 2 cases after treatment, the total eradication rate was 90.5%; 19 cases of control group were H.pylori positive, 7 cases after treatment, the total eradication rate for the 63.2%.H.pylori eradication rate in the treatment group than the control group, and the difference was statistically significant (P0.05). Results: the follow-up follow-up fourth week, treatment group and syndrome curative effect the total effective rate was 93.3%, the control group was 56.7%, there was significant difference between two groups (P0.05). The end of the treatment group were compared with follow-up syndrome at the end of the fourth week, the treatment group had no significant difference (P0.05); control group (P0.05) the clinical curative effect of 4.1.4. conclusion: Qizhu Wenzhong Decoction Treatment of spleen deficiency type chronic non atrophic gastritis exactly; 4.2 Qizhu Wenzhong Decoction in improving symptoms. In the control group; 4.3 Qizhu Wenzhong decoction can improve gastric mucosal inflammation, the curative effect is better than that of control group; 4.4 Qizu Wenzhong Decoction in the eradication of H.pylori infection than the control group; 4.5 Qizhu Wenzhong Decoction clinical efficacy of stable, long-term effect is better than the control group.

【学位授予单位】：黑龙江省中医药科学院
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R259
，

本文编号：1364397